EGCG inhibits cardiomyocyte apoptosis in pressure overload-induced cardiac hypertrophy and protects cardiomyocytes from oxidative stress in rats

被引:58
|
作者
Sheng, Rui [1 ]
Gu, Zhen-lun
Xie, Mei-lin
Zhou, Wen-xuan
Guo, Ci-yi
机构
[1] Soochow Univ, Sch Med, Dept Pharmacol, Suzhou 215123, Peoples R China
[2] Suzhou Inst Chinese Mat Med, Suzhou 215007, Peoples R China
关键词
epigallocatechin gallate; hypertrophy; apoptosis; oxidative stress; cardiac myocytes;
D O I
10.1111/j.1745-7254.2007.00495.x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Aim: To investigate the effects of epigallocatechin gallate (EGCG) on pressure overload and hydrogen peroxide (H2O2) induced cardiac myocyte apoptosis. Methods: Cardiac hypertrophy was established in rats by abdominal aortic constriction. EGCG 25, 50 and 100 mg/kg were administered intragastrically (ig). Cultured newborn rat cardiomyocytes were preincubated with EGCG, and oxida-tive stress injury was induced by H2O2. Results: In cardiac hypertrophy induced by AC in rats, relative to the model group, EGCG 25, 50 and 100 mg/kg ig for 6 weeks dose-dependently reduced systolic blood pressure (SBP) and heart weight indices, decreased malondialdehyde (MDA) content, and increased superoxide dismutase (SOD) and glutathione peroxidase (GSH-PX) activity, both in serum and in the myocardium. Also, treatment with EGCG 50 and 100 mg/kg markedly improved cardiac structure and inhibited fibrosis in HE and van Gieson (VG) stain, and reduced apoptotic myocytes in the hypertrophic myocardium detected by terminal transferase-mediated dUTP-biotin nick end-labeling (TUNEL) assay. In the Western blot analysis, EGCG significantly inhibited pressure overload-induced p53 increase and bcl-2 decrease. In H2O2-induced cardiomyocyte injury, when pr ein cu bat ed wi th myocytes for 6-48 h, EGCG 12.5-200 mg/L increased cell viability determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. EGCG also attenuated H2O2-induced lactate dehydrogenase (LDH) release and MDA formation. Meanwhile, EGCG 50 and 100 mg/L significantly inhibited the cardiomyocyte apoptotic rate in flow cytometry. Conclusion: EGCG inhibits cardiac myocyte apoptosis and oxidative stress in pressure overload induced cardiac hypertrophy. Also, EGCG prevented cardiomyocyte apoptosis from oxidative stress in vitro. The mechanism might be related to the inhibitory effects of EGCG on p53 induction and bcl-2 decrease.
引用
收藏
页码:191 / 201
页数:11
相关论文
共 50 条
  • [1] EGCG inhibits cardiomyocyte apoptosis in pressure overload-induced cardiac hypertrophy and protects cardiomyocytes from oxidative stress in rats
    Rui SHENG~(2
    3 Suzhou Institute of Chinese Materia Medica
    ActaPharmacologicaSinica, 2007, (02) : 191 - 201
  • [2] EGCG inhibits cardiomyocyte apoptosis in pressure overload-induced cardiac hypertrophy and protects cardiomyocytes from oxidative stress in rats
    Rui Sheng
    Zhen-lun Gu
    Mei-lin Xie
    Wen-xuan Zhou
    Ci-yi Guo
    Acta Pharmacologica Sinica, 2007, 28 : 191 - 201
  • [3] Lycopene protects against pressure overload-induced cardiac hypertrophy by attenuating oxidative stress
    Zeng, Junyi
    Zhao, Jingjing
    Dong, Bin
    Cai, Xingming
    Jiang, Jingzhou
    Xue, Ruicong
    Yao, Fengjuan
    Dong, Yugang
    Liu, Chen
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2019, 66 : 70 - 78
  • [4] Apigenin inhibits pressure overload-induced cardiac hypertrophy
    Dong, Xuan
    Zhou, Heng
    Zhang, Yan
    Xu, Man
    Hao, Yarong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (04): : 3772 - 3778
  • [5] Celecoxib prevents pressure overload-induced cardiac hypertrophy and dysfunction by inhibiting inflammation, apoptosis and oxidative stress
    Zhang, Chi
    Wang, Fan
    Zhang, Yingxia
    Kang, Yimin
    Wang, Haisheng
    Si, Mingming
    Su, Liping
    Xin, Xue
    Xue, Feng
    Hao, Fei
    Yu, Lechu
    Xu, Jinzhong
    Liu, Yanlong
    Xue, Mingming
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2016, 20 (01) : 116 - 127
  • [6] Mitochondrial Oxidative Stress Mediates Pressure Overload-Induced Cardiac Hypertrophy and Failure
    Dai, Dao-Fu
    Rabinovitch, Peter
    CIRCULATION RESEARCH, 2009, 105 (07) : E49 - E49
  • [7] Shensongyangxin protects against pressure overload-induced cardiac hypertrophy
    Shen, Di-Fei
    Wu, Qing-Qing
    Ni, Jian
    Deng, Wei
    Wei, Cong
    Jia, Zhen-Hua
    Zhou, Heng
    Zhou, Meng-Qiao
    Bian, Zhou-Yan
    Tang, Qi-Zhu
    MOLECULAR MEDICINE REPORTS, 2016, 13 (01) : 980 - 988
  • [8] EGCG inhibits cardiac apoptosis, telomere erosion and TRF2 loss in pressure overload induced cardiac hypertrophy in rats
    Sheng, Rui
    Gu, Zhenlun
    Xie, Meilin
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 182 - 182
  • [9] Cardiomyocyte number increases in pressure overload-induced hypertrophy
    Wilson, Rachel M.
    Chen, Xiongwen
    Kubo, Hajime
    Berretta, Remus M.
    Bearzi, Claudia
    Tillmanns, Jochen
    Leri, Annarosa
    Kajstura, Jan
    Anversa, Piero
    Houser, Steven R.
    CIRCULATION, 2006, 114 (18) : 305 - 305
  • [10] Roles of prostanoids in pressure overload-induced cardiomyocyte hypertrophy and cardiac fibrosis in mice
    Hara, A
    Yuhki, K
    Narumiya, S
    Ushikubi, F
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 193P - 193P